Published in Am Rev Respir Dis on July 01, 1982
Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol (2003) 1.88
Effect of manual percussion on tracheobronchial clearance in patients with chronic airflow obstruction and excessive tracheobronchial secretion. Thorax (1986) 1.11
Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial [ISRCTN17802078]. Crit Care (2005) 1.04
Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage. Thorax (1995) 0.97
Autogenic drainage: a modern approach to physiotherapy in cystic fibrosis. J R Soc Med (1989) 0.90
Physical activity and self treatment in cystic fibrosis. Arch Dis Child (1986) 0.84
Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity. Thorax (1994) 0.83
Primary ciliary dyskinesia. West J Med (1991) 0.82
Physiotherapy in cystic fibrosis. J R Soc Med (2000) 0.76
Airway clearance devices for cystic fibrosis: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.76
The unacceptable face of tipping. Br Med J (Clin Res Ed) (1987) 0.75
Structure and function of the mucus clearance system of the lung. Cold Spring Harb Perspect Med (2013) 0.75
Evaluation of a novel technique in airway clearance therapy - Specific Cough Technique (SCT) in cystic fibrosis: A pilot study of a series of N-of-1 randomised controlled trials. SAGE Open Med (2017) 0.75
The role of chest physiotherapy in mucus hypersecretion. Lung (1990) 0.75
Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) (1987) 4.39
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med (1990) 2.89
Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis (1981) 2.75
Management of asthma and chronic airflow limitation. Are methylxanthines obsolete? Chest (1990) 2.67
Aerosol salbutamol administration by IPPB: lowest effective dose. Thorax (1978) 2.05
Asthma therapy with aerosols: are nebulizers obsolete? A continuing controversy. J Pediatr (1999) 2.03
Control of asthma by aerosols. N Engl J Med (1986) 1.89
Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis (1987) 1.85
Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol (1976) 1.83
Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis (1988) 1.68
The effect of levamisole on cell-mediated immunity and suppressor cell function. Cancer Res (1976) 1.67
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther (1979) 1.60
Optimal delivery of aerosols from metered dose inhalers. Chest (1981) 1.59
The human splenic suppressor cell. Transplantation (1975) 1.51
Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest (1983) 1.50
Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis (1990) 1.50
The effects of preferential deposition of histamine in the human airway. Am Rev Respir Dis (1978) 1.48
Relationship between acute respiratory illness and air pollution levels in an industrial city. Am Rev Respir Dis (1977) 1.46
Rose is a rose is a rose? Aerosol therapy in ventilated patients: nebulizers versus metered dose inhalers--a continuing controversy. Am Rev Respir Dis (1993) 1.43
Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis (1977) 1.43
Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmonol (1989) 1.40
Use of scintillation camera and 135-xenon for study of topographic pulmonary function. Respir Physiol (1968) 1.39
Improvement in airway responsiveness and asthma severity during pregnancy. A prospective study. Am Rev Respir Dis (1989) 1.33
Deposition and fate of aerosolized drugs. Chest (1978) 1.29
Are active and passive smoking harmful? Determining causation. Chest (1985) 1.29
Emergency department management of life-threatening asthma. Are nebulizers obsolete? Chest (1993) 1.27
Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects. Chest (1978) 1.22
Nasal ciliary ultrastructure and function in patients with primary ciliary dyskinesia compared with that in normal subjects and in subjects with various respiratory diseases. Am Rev Respir Dis (1984) 1.17
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med (1988) 1.16
Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther (1978) 1.16
Site of beta-adrenergic receptors in the respiratory tract: use of fenoterol administered by two methods. Chest (1978) 1.15
Suppressor activity of the human spleen and thymus. Surgery (1976) 1.14
Gastroesophageal reflux and chronic respiratory disease. Am Rev Respir Dis (1984) 1.13
Aerosol penetration into the lung; influence on airway responses. Chest (1981) 1.13
Prevention of transplant renal artery stenosis. Surgery (1977) 1.09
Alveolar macrophage/peripheral blood monocyte-derived factors modulate proliferation of primary lines of human lung fibroblasts. J Leukoc Biol (1987) 1.09
Lung epithelial permeability: relation to nonspecific airway responsiveness. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.09
Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Chest (1979) 1.07
A rapid gas chromatographic method for the quantitation of underivatised individual free fatty acids in plasma. Clin Chim Acta (1975) 1.04
The dyskinetic cilia syndrome. Ciliary motility in immotile cilia syndrome. Chest (1980) 1.03
Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis. Am Rev Respir Dis (1979) 1.03
Fibrin degradation products in renal parenchymal disease states and renal transplant patients. Transplantation (1972) 1.02
Effect of induced metabolic alkalosis in hepatic encephalopathy. Lancet (1969) 1.01
Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax (1988) 1.00
Distraction osteogenesis of the mandible for airway obstruction in children. Laryngoscope (2001) 0.99
Contrast and depth enhancement in two-photon microscopy of human skin ex vivo by use of optical clearing agents. Opt Express (2005) 0.98
Release of histamine from human basophils. Blood (1967) 0.98
Metered-dose inhaler accessory devices in acute asthma: efficacy and comparison with nebulizers: a literature review. Arch Pediatr Adolesc Med (1997) 0.97
Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics. Lung (1978) 0.95
Health effects of urea formaldehyde foam insulation: evidence of causation. CMAJ (1986) 0.95
The dyskinetic cilia syndrome; abnormal ciliary motility in association with abnormal ciliary ultrastructure. Chest (1981) 0.95
Effects of exercise and eucapnic hyperventilation on bronchial clearance in man. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.93
Primary ciliary dyskinesia: evaluation and management. Pediatr Pulmonol (1988) 0.93
Chronic cough and gastroesophageal reflux. CMAJ (1989) 0.93
Ultrasonic method for detecting rejection of human renal allotransplants. Lancet (1969) 0.93
Immotile cilia syndrome in persons with and without Kartagener's syndrome. Am Rev Respir Dis (1980) 0.92
Effect of TLV levels of SO2 and H2 SO4 on bronchial clearance in exercising man. Arch Environ Health (1978) 0.91
Beclomethasone dipropionate aerosol in allergic rhinitis. Can Med Assoc J (1976) 0.91
Nasal polyposis: in search of a viral etiology using DNA hybridization. J Otolaryngol (1991) 0.89
Preterm birth at 23 to 26 weeks' gestation: is active obstetric management justified? Am J Obstet Gynecol (1987) 0.89
Inspiratory flow rates through a novel dry powder inhaler (Clickhaler) in pediatric patients with asthma. J Aerosol Med (1999) 0.89
UFFI dust: nonspecific irritant only? Chest (1982) 0.88
Are nebulizers obsolete for administering asthma medications to infants and children? Pediatr Pulmonol (1993) 0.88
Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics (2001) 0.88
Ciliary function, cell viability, and in vitro effect of ribavirin on nasal epithelial cells in acute rhinorrhea. Chest (1992) 0.88
Aerosol therapy of reversible airflow obstruction. Concepts and clinical applications. Chest (1987) 0.87
Control of asthma. Can Med Assoc J (1982) 0.86
Activation of nasal cilia in immotile cilia syndrome. Am Rev Respir Dis (1979) 0.86
Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects. J Aerosol Med (1996) 0.86
Randomized steroid therapy of human kidney transplant rejection. Transplant Proc (1979) 0.86
A controlled trial of ambroxol in chronic bronchitis. Chest (1987) 0.86
Lung deposition and clearance of inhaled (99m)Tc-heparin in healthy volunteers. Am J Respir Crit Care Med (1999) 0.85
Dipyridamole - is it a bronchodilator? Eur J Respir Dis (1981) 0.85
Suction excision biopsy for diffuse pulmonary disease. Chest (1973) 0.84
Immunosuppressive effects of antimacrophage serum and antithymocyte serum on mouse skin allografts. J Med (1972) 0.84
Medical management of hypercalcemia. Calcif Tissue Int (2003) 0.84
Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study. Am J Respir Crit Care Med (1999) 0.84
Mechanism of bronchodilator effect in chronic airflow limitation. CMAJ (1991) 0.84
Sulfur dioxide and tracheobronchial clearance in man. Arch Environ Health (1975) 0.84
Carcinogenicity of ethylmethanesulfonate. J Natl Cancer Inst (1972) 0.84
Is theophylline obsolete? Chest (1990) 0.83
Dose dependence of immunopotentiation and tumor regression induced by levamisole. Cancer Res (1977) 0.83
Renal localisation of rat cysteine dioxygenase. Nephron (2001) 0.83
Acute exposure of symptomatic steelworkers to sulphur dioxide and carbon dust: effects on mucociliary transport, pulmonary function, and bronchial reactivity. Br J Ind Med (1984) 0.83
Clinical usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation. Am Rev Respir Dis (1991) 0.82
Allopurinol modulation of fluorouracil toxicity. Cancer Chemother Pharmacol (1981) 0.82
Clonazepam in the treatment of epilepsy. Med J Aust (1974) 0.82
Tests of functional equivalence between pimozide pretreatment, extinction and free feeding. Psychopharmacology (Berl) (1988) 0.82
Clonazepam in the treatment of epilepsy. Proc Aust Assoc Neurol (1973) 0.81